loader2
Partner With Us NRI

Solara Active Pharma Sciences Ltd share Price Today

Company details

428.00
441.25
263.55
558.80
6M Return 39.76%
1Y Return 30.66%
Mkt Cap.(Cr) 1,547.65
Volume 64,169
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 64,169

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals company Solara Active Pharma Sciences announced Q1FY24 results:

  • Q1FY24 Revenues at Rs 3,544 million up 5% YoY; Reported EBITDA at Rs 200 million up 11% YoY;
  • Gross margins at 45.5% in Q1FY24 versus 41.0% in Q1FY23; YoY Improvement in Gross margins by 445 bps
  • Reported EBITDA at Rs 200 million, EBITDA margins at 5.6%; YoY Improvement in EBITDA margins by 20 bps
  • Reduction in under-recoveries at Vizag

Commenting on the financial performance, Poorvank Purohit, MD & CEO of the Company, remarked, “We are delighted to start FY24 on a positive note, after having accomplished many of the goals we set for ourselves at the beginning of the previous year. Our current priorities are to stay focused and move forward from what we had achieved in the last fiscal year. We continue to work on our key strategic priorities, which included resetting and concentrating the base business, restoring R&D velocity, addressing under-recoveries at our newly commissioned Vizag site, and expanding into new products and geographies. We are happy with the outcome of the USFDA inspection at our Cuddalore facility with Zero 483 inspectional observations. The result of these inspections demonstrates our commitment to regulatory excellence at our global manufacturing sites and our relentless focus on world-class quality and compliance.

Coming to the Q1FY24 performance, I am pleased to report that we achieved 5% YoY growth in Revenues and 11% YoY growth in EBITDA. Our order book continues to be strong. We are pleased to note the increase in demand for Ibuprofen and Ibuprofen derivatives. We continue to focus on Operating cost reduction, continuous improvement program (CIP), and inventory management. With a Strong order book position, expansion in margins, and reduced under recovery at Vizag, we have a visible growth momentum for the forthcoming quarters.”

 

Result PDF

View Other Company Results

Solara Active Pharma Sciences Ltd shares SWOT Analysis

Strengths (4)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  • Company with decreasing Promoter pledge

Weakness (6)

  • Degrowth in Revenue and Profit
  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
  • Low Piotroski Score : Companies with weak financials

Opportunity (2)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • Stock with Low PE (PE < = 10)

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 438.1
R2 446.3
R3 451.4
Pivot

433.07

S1 424.9
S2 419.8
S3 411.6
EMA SMA
436.6
436.3
417.0
394.7
435.4
451.0
413.8
369.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-04-22 584.81 276245 NSE
HRTI PRIVATE LIMITED Bulk Purchase 2024-04-22 587.59 241797 NSE
QE SECURITIES LLP Bulk Purchase 2024-04-22 588.86 236554 NSE
Name Category Shares
ARUNKUMAR PILLAI PROMOTER 4.64%
K R RAVISHANKAR PROMOTER 3.68%
PRONOMZ VENTURES LLP PROMOTER 6.48%
SRJR ENTERPRISE LLP PROMOTER 4.72%
DEVICAM CAPITAL LLP PROMOTER 2.89%
CHAYADEEP VENTURES LLP PROMOTER 2.81%
AGNUS CAPITAL LLP PROMOTER 2.36%
CHAYADEEP PROPERTIES PVT LTD PROMOTER 1.46%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Solara Active Pharma Sciences Ltd Stocks COMPARISON

Financials( in Cr) Solara Active Pharma Sciences Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 429.95 1,520.95 1,574.80 4,564.50 1,078.95
% Change -1.29 0.33 0.64 -0.53 -2.76
Mcap Cr 1,547.65 364,926.86 127,144.16 121,173.33 108,567.62
Revenue TTM Cr 1,443.81 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr -22.25 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 0.00 36.46 29.85 75.71 28.16
1 Year Return 30.66 54.15 60.91 30.94 102.68
ROCE 1.74 16.79 14.76 19.30 16.25
ROE -1.47 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,500.21 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,550.52 645.34
LAST 3M 103,712.87 -29,605.88
LAST 6M 176,931.00 -14,371.69
LAST 12M 290,309.13 100,312.35
Solara Active Pharma Sciences Limited - Press Release

Jun 12, 2024 l NSE Announcement

Solara Active Pharma Sciences closes its rights issue for raising Rs 449.95 cr

Jun 12, 2024 l BSE Announcement

Date Action Type Ratio
No data found

Solara Active Pharma Sciences Ltd Information

Stock PE (TTM)
0
Promoter Holding
30.49%
Book Value
288.334
ROCE
1.74%
ROE
-1.47%
Registered Address

201 Devavrata Sector 17 Vashi, Navi Mumbai, Mumbai, Maharashtra, 400703

Tel : 91-22-27892924
Email : investors:solara.co.in
Website : http://www.solara.co.in
Registrar

Cameo Corporate Services Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 541540
NSE Code : SOLARA
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE624Z01016

FAQ’s on Solara Active Pharma Sciences Ltd Shares

You can buy Solara Active Pharma Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Solara Active Pharma Sciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 18, 2024 03:59 PM the closing price of Solara Active Pharma Sciences Ltd was Rs.429.95.

The latest PE ratio of Solara Active Pharma Sciences Ltd as of Jun 18, 2024 03:59 PM is 0.00

The latest PB ratio of Solara Active Pharma Sciences Ltd as of Jun 18, 2024 03:59 PM is 0.67

The 52-week high of Solara Active Pharma Sciences Ltd share price is Rs. 558.80 while the 52-week low is Rs. 263.55

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 18, 2024 03:59 PM, the market cap of Solara Active Pharma Sciences Ltd stood at Rs. 1,547.65.

Download App

Download Our App

Play Store App Store
market app